300573.SZ SHZ
Shenyang Xingqi Pharmaceutical Co.,Ltd
1W: -1.2%
1M: -4.8%
3M: -13.5%
YTD: -48.5%
1Y: -39.7%
3Y: -49.1%
5Y: -10.4%
¥36.43 ($5.43)
+0.74 (+2.07%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$417M
+31.3% ▲
5Y CAGR: +41.3%
Capital Expenditures
$199M
+24.1% ▲
5Y CAGR: +23.2%
Free Cash Flow
$218M
+292.5% ▲
5Y CAGR: +121.4%
Dividends Paid
$467M
-163.4% ▼
Buybacks
$320K
+0.0% ▲
Net Change in Cash
-$118M
-314.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $93M | $209M | $212M | $240M | $338M |
| Depreciation & Amort. | $46M | $67M | $74M | $91M | $103M |
| Stock-Based Comp. | $4M | $13M | $40M | $0 | $0 |
| Change in Working Capital | -$34M | $9M | -$54M | -$53M | -$70M |
| Other Non-Cash Items | $14M | $10M | $49M | $40M | $46M |
| Operating Cash Flow | $122M | $307M | $286M | $318M | $417M |
| — Investing Activities — | |||||
| Capital Expenditures | -$108M | -$95M | -$299M | -$262M | -$199M |
| Acquisitions (Net) | $5K | $1M | $77K | $21K | $0 |
| Investment Purchases | $0 | -$130M | $0 | $0 | -$10M |
| Investment Sales | $0 | $237K | $0 | $0 | $0 |
| Other Investing | -$108M | $22M | $1 | $0 | -$7M |
| Investing Cash Flow | -$108M | -$202M | -$299M | -$262M | -$216M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$10M | $20M | -$100M | $70M | $130M |
| Stock Repurchased | -$536K | -$272K | $0 | $0 | -$320K |
| Dividends Paid | -$10M | -$41M | -$79M | -$177M | -$467M |
| Other Financing | $12M | $560M | $22M | $23M | $18M |
| Financing Cash Flow | -$15M | $538M | -$158M | -$84M | -$319M |
| Net Change in Cash | -$1M | $643M | -$171M | -$28M | -$118M |
| Cash End of Period | $37M | $680M | $509M | $480M | $363M |
| Free Cash Flow | $14M | $212M | -$13M | $56M | $218M |